1. Home
  2. GNW vs HAE Comparison

GNW vs HAE Comparison

Compare GNW & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNW
  • HAE
  • Stock Information
  • Founded
  • GNW 1871
  • HAE 1971
  • Country
  • GNW United States
  • HAE United States
  • Employees
  • GNW N/A
  • HAE N/A
  • Industry
  • GNW Life Insurance
  • HAE Medical/Dental Instruments
  • Sector
  • GNW Finance
  • HAE Health Care
  • Exchange
  • GNW Nasdaq
  • HAE Nasdaq
  • Market Cap
  • GNW 2.9B
  • HAE 3.3B
  • IPO Year
  • GNW 2004
  • HAE 1991
  • Fundamental
  • Price
  • GNW $7.93
  • HAE $76.61
  • Analyst Decision
  • GNW Buy
  • HAE Strong Buy
  • Analyst Count
  • GNW 1
  • HAE 10
  • Target Price
  • GNW $9.00
  • HAE $98.50
  • AVG Volume (30 Days)
  • GNW 7.7M
  • HAE 532.4K
  • Earning Date
  • GNW 07-30-2025
  • HAE 08-07-2025
  • Dividend Yield
  • GNW N/A
  • HAE N/A
  • EPS Growth
  • GNW 141.92
  • HAE 44.54
  • EPS
  • GNW 0.49
  • HAE 3.31
  • Revenue
  • GNW $7,217,000,000.00
  • HAE $1,360,824,000.00
  • Revenue This Year
  • GNW N/A
  • HAE N/A
  • Revenue Next Year
  • GNW N/A
  • HAE $7.18
  • P/E Ratio
  • GNW $14.93
  • HAE $22.53
  • Revenue Growth
  • GNW N/A
  • HAE 3.96
  • 52 Week Low
  • GNW $5.95
  • HAE $55.30
  • 52 Week High
  • GNW $8.00
  • HAE $94.99
  • Technical
  • Relative Strength Index (RSI)
  • GNW 64.14
  • HAE 64.74
  • Support Level
  • GNW $7.71
  • HAE $68.62
  • Resistance Level
  • GNW $7.88
  • HAE $75.59
  • Average True Range (ATR)
  • GNW 0.23
  • HAE 1.43
  • MACD
  • GNW 0.05
  • HAE 0.18
  • Stochastic Oscillator
  • GNW 89.21
  • HAE 77.69

About GNW Genworth Financial Inc

Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, Life and Annuities segment and Long-Term Care Insurance. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. Majority of the revenue is generated by the Enact segment. The company earns maximum of its revenue in the United States.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: